Meridian Bioscience (VIVO) Declares $0.125 Quarterly Dividend; 3.5% Yield
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/23/2026
- S&P 500, Nasdaq close lower, dragged by Alphabet and megacap tech; focus on Iran
- Oil settles down more 3% after US-Iran talks signal easing supply risks
- Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
- Alan Greenspan, influential former Federal Reserve chair, dies at 100
- Buy gold stocks as valuations are cheap amid macro tension: BofA
- Exclusive-China robot-hand-building unicorn Linkerbot targets $6 billion valuation
- Spain's ex-transport minister sentenced to 24 years for corruption
- Li Auto Inc. (LI) Breaks Ground on Chips R&D and Production Base
- China, US, UAE police arrest 276 telecom fraud suspects in Dubai
- Qtrex Quantum executives plan to buy up to 2M shares over 12 months
Meridian Bioscience (VIVO) Tops Q2 EPS by 3c, Beat on Revenues; Reaffirms FY Guidance
April 27, 2017 7:49 AM EDTMeridian Bioscience (NASDAQ: VIVO) reported Q2 EPS of $0.22, $0.03 better than the analyst estimate of $0.19. Revenue for the quarter came in at $54.1 million versus the consensus estimate of $51.16 million.
Reaffirmed fiscal 2017 guidance of per share diluted earnings between $0.64 and $0.69 on net revenues of $193... More
